Department of Plastic Surgery, University of Texas Southwestern, Dallas, TX.
Aesthet Surg J. 2019 Nov 13;39(12):1331-1341. doi: 10.1093/asj/sjz006.
The number of patients seeking augmentation mastopexy has increased over the last several decades. The conflicting goals of augmentation (tissue expansion) and mastopexy (tissue reduction) have led to higher revision rates, decreased patient satisfaction, and pending litigation. Some have even argued for staging of all augmentation mastopexy procedures.
The goal of this study was to review the senior author's (W.P.A.) process-oriented approach to single-stage augmentation mastopexy and to detail the technical framework to produce reliable, reproducible, safe results in a 1-stage augmentation mastopexy.
A prospectively collected patient database from January 2007 until January 2018 was reviewed. All single-stage augmentation mastopexy patients were evaluated, including patient demographics, operative details, complications, and outcomes.
A total of 251 patients were evaluated. Mean follow-up was 16.9 months, average patient age was 38.0 years, and average implant size was 285.8 cc. A total of 9 (3.6%) patients required reoperation and only 2 (0.8%) required explantation. Fourteen (5.6%) patients developed delayed wound healing that responded to local wound care alone.
Utilization of a safe and reliable processed approach to single-stage augmentation mastopexy is highly predictable with low reoperation rates. The technical refinements presented have led to increased consistency in delivering high-quality results to patients in a procedure fraught with challenges.
在过去几十年中，寻求隆胸乳房上提术的患者数量有所增加。隆胸（组织扩张）和乳房上提术（组织减少）的目标相互冲突，导致更高的修复率、降低的患者满意度和待决的诉讼。有些人甚至主张对所有隆胸乳房上提术进行分期。
本研究的目的是回顾资深作者（W.P.A.）的单阶段隆胸乳房上提术的面向过程方法，并详细介绍在单阶段隆胸乳房上提术中产生可靠、可重复、安全结果的技术框架。
回顾了 2007 年 1 月至 2018 年 1 月期间前瞻性收集的患者数据库。评估了所有单阶段隆胸乳房上提术患者，包括患者人口统计学、手术细节、并发症和结果。
共评估了 251 名患者。平均随访时间为 16.9 个月，平均患者年龄为 38.0 岁，平均植入物大小为 285.8cc。共有 9 名（3.6%）患者需要再次手术，只有 2 名（0.8%）需要取出植入物。14 名（5.6%）患者出现延迟愈合，仅通过局部伤口护理即可治愈。
采用安全可靠的单阶段隆胸乳房上提术处理流程方法具有高度可预测性，且修复率低。所提出的技术改进使在充满挑战的手术中为患者提供高质量结果的一致性得到提高。
